By pairing copper peptides for collagen with hormone optimization, nutritional support, and other regenerative options, the team focuses on both visible results and the underlying biology that drives how you age
Payer Strategies for GLP-1s Used to Treat Obesity Comorbidities The FDA approval of Zepbound for OSA is expected to impact coverage and management strategies across the payer landscape
Heres how it works: Stimulates VEGF (vascular endothelial growth factor) to enhance blood flow to damaged tissue Increases fibroblast activity for tendon and ligament matrix rebuilding Accelerates collagen synthesis to restore connective tissue integrity Inhibits pro-inflammatory cytokines to reduce pain and swelling Stabilizes nitric oxide pathways for optimal healing and anti-inflammatory effects BPC157 accelerates tendon and muscle healing by enhancing angiogenesis, modulating growth factors, and reducing pro-inflammatory markers. Gwyer et al., Journal of Orthopaedic Research Unlike growth hormone or testosterone derivatives, BPC157 works locally and systemically , repairing tissue without inducing hypertrophy or altering hormone levels
Some recovery protocols are short and finite
At 36 weeks, the 12mg dose produced 16.9% body weight reduction in this population, somewhat less than the 24% seen in the general obesity population but still clinically significant
Supplementary Table S3)